First Trust Advisors
RLAY icon

First Trust Advisors’s Relay Therapeutics RLAY Stock Holding History

First Trust Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1M Buy
+1,075,126
New +$15.6M 0.01% 933
2025
Q1 		– Sell
-89,949
Closed -$371K – 2607
2024
Q4 		$371K Buy
+89,949
New +$489K ﹤0.01% 2328
2024
Q2 		– Sell
-118,644
Closed -$985K – 2407
2024
Q1 		$985K Buy
+118,644
New +$1.16M ﹤0.01% 1987
2023
Q1 		– Sell
-13,234
Closed -$198K – 2452
2022
Q4 		$198K Sell
13,234
-54,163
-80% -$1.04M ﹤0.01% 2375
2022
Q3 		$1.51M Buy
67,397
+53,014
+369% +$1.16M ﹤0.01% 1827
2022
Q2 		$241K Buy
+14,383
New +$308K ﹤0.01% 2352

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

First Trust Advisors's RLAY Position: Q2 2026 in Review

First Trust Advisors opened a new position in Relay Therapeutics (RLAY) in Q2 2026: 1,075,126 shares worth $20.1M. The stake represents 0.01% of the portfolio and ranks #933 among its holdings. This is a return to the name: First Trust Advisors previously reported a position in RLAY as recently as Q4 2024.

First Trust Advisors first reported a position in RLAY in Q2 2022 and has held it in 6 quarters since. 260 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • First Trust Advisors held 1,075,126 shares of Relay Therapeutics worth $20.1M as of Q2 2026.
  • Relay Therapeutics was a new First Trust Advisors position in Q2 2026.
  • Relay Therapeutics made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #933 holding.
  • First Trust Advisors first reported a position in Relay Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • 260 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.